vs
Dayforce（DAY）与登士柏西诺德（XRAY）财务数据对比。点击上方公司名可切换其他公司
登士柏西诺德的季度营收约是Dayforce的2.0倍（$961.0M vs $481.6M），登士柏西诺德净利率更高（-15.2% vs -40.9%，领先25.7%），Dayforce同比增速更快（9.5% vs 6.2%），过去两年Dayforce的营收复合增速更高（9.8% vs 0.4%）
Dayforce前身为知名人力资源服务商Ceridian，是一家总部位于美国的人力资源软件及服务企业，面向各行业不同规模的客户提供覆盖薪酬核算、人员管理、考勤等多场景的HR SaaS产品及配套专业服务，助力企业提升人力资源运营效率。
登士柏西诺德是美国牙科设备及耗材制造商，业务覆盖全球120多个国家，在21个国家设有生产工厂。该公司前身为1993年Gendex公司以5.9亿美元收购登士柏国际后整合组建的企业，是全球牙科领域的重要供应商。
DAY vs XRAY — 直观对比
营收规模更大
XRAY
是对方的2.0倍
$481.6M
营收增速更快
DAY
高出3.3%
6.2%
净利率更高
XRAY
高出25.7%
-40.9%
两年增速更快
DAY
近两年复合增速
0.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $481.6M | $961.0M |
| 净利润 | $-196.8M | $-146.0M |
| 毛利率 | — | 46.1% |
| 营业利润率 | 6.3% | -14.5% |
| 净利率 | -40.9% | -15.2% |
| 营收同比 | 9.5% | 6.2% |
| 净利润同比 | -9940.0% | 66.0% |
| 每股收益（稀释后） | $-1.23 | $-0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAYXRAY
| Q4 25 | — | $961.0M | ||
| Q3 25 | $481.6M | $904.0M | ||
| Q2 25 | $464.7M | $936.0M | ||
| Q1 25 | $481.8M | $879.0M | ||
| Q4 24 | $465.2M | $905.0M | ||
| Q3 24 | $440.0M | $951.0M | ||
| Q2 24 | $423.3M | $984.0M | ||
| Q1 24 | $431.5M | $953.0M |
净利润DAYXRAY
| Q4 25 | — | $-146.0M | ||
| Q3 25 | $-196.8M | $-427.0M | ||
| Q2 25 | $21.3M | $-45.0M | ||
| Q1 25 | $14.9M | $20.0M | ||
| Q4 24 | $10.8M | $-430.0M | ||
| Q3 24 | $2.0M | $-494.0M | ||
| Q2 24 | $-1.8M | $-4.0M | ||
| Q1 24 | $7.1M | $18.0M |
毛利率DAYXRAY
| Q4 25 | — | 46.1% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 52.4% | ||
| Q1 25 | — | 53.0% | ||
| Q4 24 | 47.0% | 49.3% | ||
| Q3 24 | 45.8% | 52.1% | ||
| Q2 24 | 44.1% | 51.9% | ||
| Q1 24 | 47.6% | 53.1% |
营业利润率DAYXRAY
| Q4 25 | — | -14.5% | ||
| Q3 25 | 6.3% | -24.1% | ||
| Q2 25 | 9.1% | -13.7% | ||
| Q1 25 | 6.4% | 7.2% | ||
| Q4 24 | 6.1% | -56.2% | ||
| Q3 24 | 4.7% | -48.6% | ||
| Q2 24 | 3.3% | 5.1% | ||
| Q1 24 | 9.4% | 4.4% |
净利率DAYXRAY
| Q4 25 | — | -15.2% | ||
| Q3 25 | -40.9% | -47.2% | ||
| Q2 25 | 4.6% | -4.8% | ||
| Q1 25 | 3.1% | 2.3% | ||
| Q4 24 | 2.3% | -47.5% | ||
| Q3 24 | 0.5% | -51.9% | ||
| Q2 24 | -0.4% | -0.4% | ||
| Q1 24 | 1.6% | 1.9% |
每股收益（稀释后）DAYXRAY
| Q4 25 | — | $-0.74 | ||
| Q3 25 | $-1.23 | $-2.14 | ||
| Q2 25 | $0.13 | $-0.22 | ||
| Q1 25 | $0.09 | $0.10 | ||
| Q4 24 | $0.07 | $-2.09 | ||
| Q3 24 | $0.01 | $-2.46 | ||
| Q2 24 | $-0.01 | $-0.02 | ||
| Q1 24 | $0.04 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $627.6M | $326.0M |
| 总债务越低越好 | $631.1M | $2.3B |
| 股东权益账面价值 | $2.7B | $1.3B |
| 总资产 | $8.7B | $5.4B |
| 负债/权益比越低杠杆越低 | 0.23× | 1.70× |
8季度趋势，按日历期对齐
现金及短期投资DAYXRAY
| Q4 25 | — | $326.0M | ||
| Q3 25 | $627.6M | $363.0M | ||
| Q2 25 | $625.2M | $359.0M | ||
| Q1 25 | $557.3M | $398.0M | ||
| Q4 24 | $579.7M | $272.0M | ||
| Q3 24 | $494.1M | $296.0M | ||
| Q2 24 | $465.4M | $279.0M | ||
| Q1 24 | $392.5M | $291.0M |
总债务DAYXRAY
| Q4 25 | — | $2.3B | ||
| Q3 25 | $631.1M | — | ||
| Q2 25 | $631.8M | — | ||
| Q1 25 | $632.4M | — | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益DAYXRAY
| Q4 25 | — | $1.3B | ||
| Q3 25 | $2.7B | $1.5B | ||
| Q2 25 | $2.7B | $2.0B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.5B | $1.9B | ||
| Q3 24 | $2.6B | $2.5B | ||
| Q2 24 | $2.5B | $3.1B | ||
| Q1 24 | $2.4B | $3.3B |
总资产DAYXRAY
| Q4 25 | — | $5.4B | ||
| Q3 25 | $8.7B | $5.7B | ||
| Q2 25 | $8.5B | $6.1B | ||
| Q1 25 | $9.5B | $6.0B | ||
| Q4 24 | $9.1B | $5.8B | ||
| Q3 24 | $8.1B | $6.6B | ||
| Q2 24 | $9.0B | $6.9B | ||
| Q1 24 | $10.8B | $7.1B |
负债/权益比DAYXRAY
| Q4 25 | — | 1.70× | ||
| Q3 25 | 0.23× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.47× | 0.90× | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.2M | $101.0M |
| 自由现金流经营现金流 - 资本支出 | — | $60.0M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | — | 4.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $104.0M |
8季度趋势，按日历期对齐
经营现金流DAYXRAY
| Q4 25 | — | $101.0M | ||
| Q3 25 | $31.2M | $79.0M | ||
| Q2 25 | $112.7M | $48.0M | ||
| Q1 25 | $49.6M | $7.0M | ||
| Q4 24 | $81.0M | $87.0M | ||
| Q3 24 | $91.8M | $141.0M | ||
| Q2 24 | $99.2M | $208.0M | ||
| Q1 24 | $9.1M | $25.0M |
自由现金流DAYXRAY
| Q4 25 | — | $60.0M | ||
| Q3 25 | — | $40.0M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $-12.0M | ||
| Q4 24 | — | $36.0M | ||
| Q3 24 | — | $98.0M | ||
| Q2 24 | — | $156.0M | ||
| Q1 24 | — | $-9.0M |
自由现金流率DAYXRAY
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | -1.4% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 10.3% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | -0.9% |
资本支出强度DAYXRAY
| Q4 25 | — | 4.3% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 3.6% |
现金转化率DAYXRAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.29× | — | ||
| Q1 25 | 3.33× | 0.35× | ||
| Q4 24 | 7.50× | — | ||
| Q3 24 | 45.90× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.28× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
XRAY
| Essential Dental Solutions | $372.0M | 39% |
| Equipment And Instruments | $160.0M | 17% |
| Implants And Prosthetics | $150.0M | 16% |
| CADCAM | $139.0M | 14% |
| Wellspect Healthcare | $88.0M | 9% |
| Orthodontics | $52.0M | 5% |
